Cenexel HRI

Berlin, New Jersey 08053

2 studies enrolling now · 13 studies all time

What they study most

Allergy, Peanut, Diabetes Mellitus, Type 2, Fatty Liver, Herpes Zoster (HZ), High Triglycerides, Hypertension, Hypertension (HTN), Infectious Disease, Major Depressive Disorder, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Post Traumatic Stress Disorder

Studies at this site

• An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. — Recruiting now
• Drug Screening System Method Comparison — Recruiting now
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) — Running, not enrolling
• A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients — Running, not enrolling
• Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts — Completed
• A Study to Assess the Use of Methylone in the Treatment of PTSD — Completed
• A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder — Completed
• Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia — Completed
• BPL-003 Efficacy and Safety in Treatment Resistant Depression — Completed
• Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia — Completed
• Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis — Running, not enrolling
• A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine — Completed
• A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed